Description
Amgevita is a biosimilar adalimumab injection available as a solution in pre-filled autoinjectors and syringes. It is indicated for the treatment of various autoimmune diseases such as rheumatoid arthritis and plaque psoriasis. As of 2025, it includes high-concentration formulations (20mg/0.2ml and 40mg/0.4ml) and is eligible for government subsidies in Singapore under the Ministry of Health (MOH) Standard Drug List.
Best for
Government subsidy eligibility, Rheumatoid arthritis, High Concentration formulation and Standard drug list access